亚专科培训放射科医师在胰腺腺癌多学科肿瘤委员会中的附加价值:系统综述与Meta分析
该系统综述与Meta分析评估亚专科放射科医师在胰腺腺癌多学科团队中的作用及对患者结局的影响,纳入10项研究共2067例患者。影像复核后约44%患者的治疗方案发生改变,但研究间差异大(18%-74%);无研究显示仅因多学科团队参与即带来统计学显著的生存获益。
要点
- 多学科团队中纳入亚专科放射科医师复核影像后,约44%胰腺腺癌患者治疗方案发生改变。
- 治疗方案改变比例的研究间不确定性大,范围为18%-74%,与分组、改变定义及本地实践差异有关。
- 无研究显示仅因多学科团队参与即带来统计学显著的生存获益。
核心结论
- 多学科团队会议中的影像复核可提供关键信息并导致治疗管理改变,但各研究间改变比例差异大(18%-74%),且无研究显示仅因多学科团队参与即带来统计学显著的生存获益。
研究设计与样本
- 系统综述与随机效应Meta分析,检索Ovid MEDLINE、Ovid Embase、Cochrane系统综述数据库、Cochrane对照试验中心注册库及Web of Science至2023年8月31日,纳入10项研究(4项回顾性、6项前瞻性;4项多中心、6项单中心)共2067例患者。
诊断标准与关键数值
- 3项研究共977例患者显示多学科团队影像复核后患者管理有简洁改变,平均估计值为0.53(95%CI 0.50-0.56);随机效应Meta分析显示约44%患者在多学科团队会议纳入亚专科培训放射科医师后治疗方案发生改变,范围18%-74%。
临床应用与阅片要点
- 原文指出多学科团队中的影像复核可提供关键信息并影响临床决策,同时提到在三级中心之外开展稳健多学科团队举措可能存在资源不足的适用性顾虑。
局限性
- 治疗方案改变比例的研究间不确定性大(18%-74%),源于研究分组、对「改变」的定义及本地实践差异。
- 两项研究强调即使多学科团队输入有价值,不同团队之间甚至同一团队随时间推移的解释也可能存在差异。
- 无研究显示仅因多学科团队参与即带来统计学显著的生存获益,可能因总生存取决于许多下游因素。
- 三级中心之外可能缺乏资源开展稳健的多学科团队举措,存在适用性顾虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To perform a systematic review assessing the role of subspecialty radiologist in a multidisciplinary team (MDT) focused on pancreatic adenocarcinoma (PDAC) and the impact on patient outcomes.
METHODS AND MATERIALS: Ovid MEDLINE, Ovid Embase, Cochrane Database of Systematic Reviews (Ovid), Cochrane Central Register of Controlled Trials (Ovid), and Web of Science searched until August 31, 2023, for studies including radiology review in PDAC MDT. Data extraction, risk of bias, and applicability assessment were performed by two authors. Random-effects meta-analysis was performed.
RESULTS: Ten studies (four retrospective, six prospective, and four multi-center vs. six single center), including 2,067 patients, met inclusion criteria in a pool of 13,043 studies. Three studies including 977 patients demonstrated succinct changes in patient management (average estimate 0.53 (95% CI 0.50-0.56)) after a radiology review at the MDT. A random-effects meta-analysis of these studies show that approximately 44% of patients had their treatment plans changed after a meeting at the MDT that included a subspecialty trained radiologist, but there is a large range of uncertainty (18%-74%) due to differences in the studies' groups, what they considered a "change" and local practices. Two studies highlighted an important nuance: while MDT input is valuable, the interpretations can vary between teams or even within the same team over time, reflecting the complex nature of PDAC. None of the studies showed a statistically significant survival advantage solely from MDT involvement, likely because overall survival depends on many downstream factors.
CONCLUSIONS: The presence of radiology review in the setting of multidisciplinary team meetings provides crucial information, leading to management changes. Future studies could explore advanced imaging modalities such as PET-MRI and establish the impact of intra/interobserver variability within the multidisciplinary team.
CLINICAL RELEVANCE/APPLICATION: This work highlights the ongoing involvement of subspecialty trained radiologists in the multidisciplinary team for PDAC, and it significantly influences clinical decisions. Applicability concerns exist due to a potential lack of resources for robust MDT initiatives outside of tertiary centers.
引用
- Caulfield A, Nanda B, Farrell A, et al. Value addition by subspecialty trained radiologists in multidisciplinary tumor boards for pancreatic adenocarcinoma: a systematic review and meta-analysis. Radiol Med. 2025. PMID: 41166033. doi:10.1007/s11547-025-02139-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。